|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4754065A
(en)
|
1984-12-18 |
1988-06-28 |
Cetus Corporation |
Precursor to nucleic acid probe
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
GB2183661B
(en)
|
1985-03-30 |
1989-06-28 |
Marc Ballivet |
Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US5837249A
(en)
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
|
US4818700A
(en)
|
1985-10-25 |
1989-04-04 |
Phillips Petroleum Company |
Pichia pastoris argininosuccinate lyase gene and uses thereof
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US4812405A
(en)
|
1986-02-18 |
1989-03-14 |
Phillips Petroleum Company |
Double auxotrophic mutants of Pichia pastoris and methods for preparation
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
EP0279582A3
(en)
|
1987-02-17 |
1989-10-18 |
Pharming B.V. |
Dna sequences to target proteins to the mammary gland for efficient secretion
|
|
US5202231A
(en)
|
1987-04-01 |
1993-04-13 |
Drmanac Radoje T |
Method of sequencing of genomes by hybridization of oligonucleotide probes
|
|
US6270961B1
(en)
|
1987-04-01 |
2001-08-07 |
Hyseq, Inc. |
Methods and apparatus for DNA sequencing and DNA identification
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5686073A
(en)
|
1990-05-23 |
1997-11-11 |
The University Of Iowa Research Foundation |
Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
|
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
US5278144A
(en)
*
|
1990-09-04 |
1994-01-11 |
Cor Therapeutics, Inc. |
Antithrombosis agents
|
|
US5597799A
(en)
*
|
1990-09-04 |
1997-01-28 |
Cor Therapeutics, Inc. |
Recombinant agents affecting thrombosis
|
|
US5583107A
(en)
|
1990-09-04 |
1996-12-10 |
Cor Therapeutics, Inc. |
Agents affecting thrombosis and hemostasis
|
|
WO1992013878A2
(en)
|
1991-02-07 |
1992-08-20 |
Board Of Trustees Of The University Of Illinois |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
US6797492B2
(en)
|
1991-05-17 |
2004-09-28 |
Merck & Co., Inc. |
Method for reducing the immunogenicity of antibody variable domains
|
|
WO1993006126A1
(en)
|
1991-09-13 |
1993-04-01 |
Chiron Corporation |
Immunoreactive hepatitis c virus polypeptide compositions
|
|
DE69232137T2
(de)
|
1991-11-25 |
2002-05-29 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
DE4203965A1
(de)
*
|
1992-02-11 |
1993-08-12 |
Max Planck Gesellschaft |
Antidot fuer hirudin und synthetische thrombininhibitoren
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
US5858659A
(en)
|
1995-11-29 |
1999-01-12 |
Affymetrix, Inc. |
Polymorphism detection
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
US5952172A
(en)
|
1993-12-10 |
1999-09-14 |
California Institute Of Technology |
Nucleic acid mediated electron transfer
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
US5589571A
(en)
*
|
1994-10-28 |
1996-12-31 |
Cor Therapeutics, Inc. |
Process for production of inhibited forms of activated blood factors
|
|
AT404357B
(de)
|
1995-06-13 |
1998-11-25 |
Immuno Ag |
Prothrombin-derivate
|
|
US5968740A
(en)
|
1995-07-24 |
1999-10-19 |
Affymetrix, Inc. |
Method of Identifying a Base in a Nucleic Acid
|
|
US5955349A
(en)
|
1996-08-26 |
1999-09-21 |
Zymogenetics, Inc. |
Compositions and methods for producing heterologous polypeptides in Pichia methanolica
|
|
DE19605126A1
(de)
|
1996-02-12 |
1997-08-14 |
Basf Ag |
Thrombinmuteine als Antidot für Thrombininhibitoren
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US6200955B1
(en)
|
1996-06-11 |
2001-03-13 |
Commonwealth Biotechnologies, Inc. |
Heparin binding peptides
|
|
US5736383A
(en)
|
1996-08-26 |
1998-04-07 |
Zymogenetics, Inc. |
Preparation of Pichia methanolica auxotrophic mutants
|
|
US6709659B1
(en)
|
1996-08-02 |
2004-03-23 |
Zymogenetics, Inc. |
Antibodies that bind testis-specific insulin homolog polypeptides
|
|
SE9604744D0
(sv)
*
|
1996-12-20 |
1996-12-20 |
Pharmacia & Upjohn Ab |
A modified coagulation agent
|
|
SE9700422D0
(sv)
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Single dose inhaler II
|
|
US6051563A
(en)
*
|
1997-02-12 |
2000-04-18 |
U.S. Bioscience, Inc. |
Methods for the administration of amifostine and related compounds
|
|
AT405517B
(de)
|
1997-02-27 |
1999-09-27 |
Immuno Ag |
Faktor x-deletionsmutanten und analoge davon
|
|
AT405516B
(de)
*
|
1997-02-27 |
1999-09-27 |
Immuno Ag |
Faktor x-analoge mit modifizierter proteasespaltstelle
|
|
AU6673898A
(en)
|
1997-03-07 |
1998-09-22 |
Washington University |
Factor x variant
|
|
JPH1149800A
(ja)
*
|
1997-06-05 |
1999-02-23 |
Fujimori Kogyo Kk |
アンヒドロトロンビンの合成方法
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
US6322788B1
(en)
|
1998-08-20 |
2001-11-27 |
Stanley Arthur Kim |
Anti-bacterial antibodies and methods of use
|
|
AU1728800A
(en)
|
1998-11-18 |
2000-06-05 |
Genentech Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
|
AU3629800A
(en)
*
|
1999-03-16 |
2000-10-04 |
Children's Hospital Of Philadelphia, The |
Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors
|
|
US6624141B1
(en)
|
1999-03-17 |
2003-09-23 |
The Regents Of The University Of Michigan |
Protamine fragment compositions and methods of use
|
|
US6258559B1
(en)
|
1999-03-22 |
2001-07-10 |
Zymogenetics, Inc. |
Method for producing proteins in transformed Pichia
|
|
US6939545B2
(en)
|
1999-04-28 |
2005-09-06 |
Genetics Institute, Llc |
Composition and method for treating inflammatory disorders
|
|
EP1095933A1
(en)
*
|
1999-10-30 |
2001-05-02 |
Aventis Pharma Deutschland GmbH |
Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
|
|
AU2001250783A1
(en)
*
|
2000-02-29 |
2001-09-12 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
WO2001068605A1
(en)
*
|
2000-03-13 |
2001-09-20 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
|
|
JP2004509617A
(ja)
|
2000-09-08 |
2004-04-02 |
シェーリング コーポレイション |
哺乳動物遺伝子；関連試薬および方法
|
|
US7070740B1
(en)
|
2000-09-28 |
2006-07-04 |
Beckman Coulter, Inc. |
Method and apparatus for processing biomolecule arrays
|
|
US20030064414A1
(en)
*
|
2001-03-30 |
2003-04-03 |
Benecky Michael J. |
Rapid assessment of coagulation activity in whole blood
|
|
US7138506B2
(en)
|
2001-05-09 |
2006-11-21 |
Genetic Id, Na, Inc. |
Universal microarray system
|
|
US6989267B2
(en)
|
2001-07-02 |
2006-01-24 |
Agilent Technologies, Inc. |
Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films
|
|
US20040198660A1
(en)
*
|
2002-11-06 |
2004-10-07 |
Petersen Lars Christian |
Tissue factor antagonist and protein C polypeptide compositions
|
|
US7247654B2
(en)
*
|
2003-06-04 |
2007-07-24 |
Bristol-Myers Squibb Company |
3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
|
|
NZ545494A
(en)
*
|
2003-09-12 |
2009-10-30 |
Pfizer |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
EP1723422A2
(en)
|
2004-03-05 |
2006-11-22 |
The Scripps Research Institute |
High throughput glycan microarrays
|
|
JP4441336B2
(ja)
|
2004-06-11 |
2010-03-31 |
日本碍子株式会社 |
マイクロアレイの製造方法
|
|
US9223929B2
(en)
|
2005-03-14 |
2015-12-29 |
The California Institute Of Technology |
Method and apparatus for detection, identification and quantification of single-and multi-analytes in affinity-based sensor arrays
|
|
US7119179B1
(en)
|
2005-03-21 |
2006-10-10 |
Los Alamos National Security, Llc |
Preparation of high nitrogen compound and materials therefrom
|
|
WO2006102687A1
(en)
|
2005-03-22 |
2006-09-28 |
The Trustees Of Columbia University In The City Of New York |
A liposome-based microarray and methods of use thereof
|
|
NZ592533A
(en)
|
2005-11-08 |
2012-08-31 |
Millennium Pharm Inc |
METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR
|
|
MX336958B
(es)
|
2005-11-15 |
2016-02-05 |
Philadelphia Children Hospital |
Metodos y composiciones para modular la hemostasia.
|
|
US20070111322A1
(en)
|
2005-11-15 |
2007-05-17 |
Lin-Cheng Yang |
Novel method of using inject printing for creating microarrays
|
|
EP1820508A1
(en)
|
2006-02-21 |
2007-08-22 |
CSL Behring GmbH |
Coagulation factor X polypeptides with modified activation properties
|
|
CN105193799A
(zh)
|
2006-12-08 |
2015-12-30 |
米伦纽姆医药公司 |
使用经口因子xa抑制剂治疗血栓形成的单位剂量调配物和方法
|
|
US20100189723A1
(en)
*
|
2007-01-11 |
2010-07-29 |
Peter Andreas Nicolai Reumert Wagtmann |
Anti-kir antibodies, formulations, and uses thereof
|
|
KR102069498B1
(ko)
*
|
2007-09-28 |
2020-01-23 |
포톨라 파마슈티컬스, 인코포레이티드 |
인자 Ｘａ 저해제에 대한 안티도트 및 그것을 사용하는 방법
|
|
EP2364165B1
(en)
*
|
2008-11-14 |
2018-01-03 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
|
|
KR20110114587A
(ko)
|
2008-12-19 |
2011-10-19 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
세린 프로테아제 유도체 및 혈액응고 장애의 치료 또는 예방의 용도
|
|
PL3604510T3
(pl)
*
|
2009-03-30 |
2025-07-28 |
Alexion Pharmaceuticals, Inc. |
Antidota na inhibitory czynnika xa i sposoby ich stosowania
|
|
PT2453910T
(pt)
*
|
2009-07-15 |
2016-12-07 |
Portola Pharm Inc |
Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
|
|
HK1205188A1
(en)
*
|
2012-02-14 |
2015-12-11 |
Portola Pharmaceuticals, Inc. |
Process for making recombinant antidote to factor xa inhibitor
|